|
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C.Thomson, Laura E. Rosen, James G. Shepherd, Roberto Spreafico, Anada Silva Filipe, Jason A. Wojcechowskyj, Chris Davis, Luca Picco, David J. Pascal, Josh Dillen, Spyros Lytras, Nadine Czudnochowski, Rajiv Shah, Marcel Meury, Natasha Jesudason, Anna De Marco, Kathy Li, Jessica Bassi … Gyorgy Snell |
|||
| https://www.sciencedirect.com/science/article/pii/S009286742... | ||||
|
|
BOLETÍN SEMANAL COVID-19. Vol. 2 No. 25. 05 febrero 2021 | |||
| http://files.sld.cu/sars/files/2021/02/SEMANAL-25-nuevo.pdf | ||||
|
|
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Viviane C Veiga, João A G G Prats, Danielle L C Farias, Regis G Rosa, Leticia K Dourado, Fernando G Zampieri, Flávia R Machado, Renato D Lopes, , Otavio Berwanger, Luciano C P Azevedo, Álvaro Avezum, Thiago C Lisboa, Salomón S O Rojas, Juliana C Coelho, Rodrigo T Leite, Júlio C Carvalho, Luis E C Andrade, Alex F Sandes, Maria C T Pintão, Claudio G Castro Jr, Sueli V Santos, Thiago M L de... |
|||
| https://www.bmj.com/content/372/bmj.n84 | ||||
|
|
Where covid contact-tracing went wrong?
Dyani Lewis |
|||
| https://media.nature.com/original/magazine-assets/d41586-020... | ||||
|
|
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, Anna V Kovyrshina, Nadezhda L Lubenets, Daria M Grousova, Alina S Erokhova, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V... |
|||
| https://www.thelancet.com/journals/lancet/article/PIIS0140-6... | ||||
|
|
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19. A Randomized Clinical Trial
Robert L. Gottlieb, Ajay Nirula, Peter Chen, Joseph Boscia, Barry Heller, Jason Morris, Gregory Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, Princy Kumar, Andrew C. Adams, Jacob Van Naarden, Kenneth L. Custer, Michael Durante, Gerard Oakley, Andrew E. Schade, Timothy R. Holzer, Philip J. Ebert, Richard E. Higgs, Nicole L. Kallewaard, Janelle Sabo, Dipak R. Patel, Paul... |
|||
| https://jamanetwork.com/journals/jama/fullarticle/2775647 | ||||
|
|
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia
Letterio S. Politi, Ettore Salsano, Marco Grimaldi |
|||
| https://jamanetwork.com/journals/jamaneurology/fullarticle/2... | ||||
|
|
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White, Romel Rosales, Soner Yildiz, Thomas Kehrer, Lisa Miorin, Elena Moreno, Sonia Jangra, Melissa B. Uccellini, Raveen Rathnasinghe, Lynda Coughlan, Carles Martinez-Romero, Jyoti Batra, Ajda Rojc, Mehdi Bouhaddou, Jacqueline M. Fabius, Kirsten Obernier, Marion Dejosez, María José Guillén, Alejandro Losada, Pablo Avilés, Michael Schotsaert, Thomas Zwaka, Marco Vignuzzi, Kevan M. Shokat,... |
|||
| https://science.sciencemag.org/content/early/2021/01/22/scie... | ||||
|
|
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr, Allison J. Greaney, Amin Addetia, William W. Hannon, Manish C. Choudhary, Adam S. Dingens, Jonathan Z. Li, Jesse D. Bloom |
|||
| https://science.sciencemag.org/content/early/2021/01/22/scie... | ||||
|
|
Vaccine 2.0: Moderna and other companies plan tweaks that would protect against new coronavirus mutations
Kai Kupferschmidt |
|||
| https://www.sciencemag.org/news/2021/01/vaccine-20-moderna-a... | ||||
|
|
Una mirada a las vacunas contra COVID-19: la mejor estrategia para acabar con la pandemia
Carol Perelman |
|||
| http://www.acmor.org/articulo/una-mirada-las-vacunas-contra-... | ||||
|
|
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Marloes Grobben, Mathieu Claireaux, Marlon de Gast, Romain Marlin, Virginie Chesnais, Ségolène Diry, View ORCID ProfileJoel D. Allen, Yasunori Watanabe, Julia M. Giezen, Gius Kerster, Hannah L. Turner, Karlijn van der Straten, Cynthia A. van der Linden, Yoann Aldon, Thibaut Naninck, Ilja Bontjer, Judith A.... |
|||
| https://www.biorxiv.org/content/10.1101/2020.11.07.365726v1 | ||||
|
|
BOLETÍN SEMANAL COVID-19. Vol. 2 No. 24. 29 de enero 2020 | |||
| http://files.sld.cu/sars/files/2021/01/SEMANAL-24.pdf | ||||
|
|
Modelo inspirado en un proceso hidrológico para el pronóstico de escenarios de contagio de la COVID-19
YOEL MARTÍNEZ GONZÁLEZ, DANIEL GARCÍA CORTÉS |
|||
| http://revistaccuba.sld.cu/index.php/revacc/article/view/869 | ||||
|
|
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen, Ajay Nirula, Barry Heller, Robert L. Gottlieb, Joseph Boscia, Jason Morris, Gregory Huhn, Jose Cardona, Bharat Mocherla, Valentina Stosor, Imad Shawa, Andrew C. Adams, Jacob Van Naarden, Kenneth L. Custer, Lei Shen, Michael Durante, Gerard Oakley, Andrew E. Schade, Janelle Sabo, Dipak R. Patel, Paul Klekotka, and Daniel M. Skovronsky, for the BLAZE-1 Investigators |
|||
| https://www.nejm.org/doi/full/10.1056/NEJMoa2029849 | ||||
Crear cuenta